Schmitt Andy, Tourette Claire, Pivano Audrey, Rambeaud Caroline, Loundou Anderson, Agostini Aubert
Department of Gynecology, Obstetrics, and Reproduction, Gynepôle, Hôpital de la Conception, Marseille, France (Dr Schmitt, Dr Tourette, Dr Pivano, Dr Rambeaud, and Dr Agostini).
Department of Public Health, Aix-Marseille University, Marseille, France (Dr Loundou).
AJOG Glob Rep. 2023 May 21;3(3):100223. doi: 10.1016/j.xagr.2023.100223. eCollection 2023 Aug.
Pregnancy of unknown location (PUL) is a term used when there is a positive pregnancy test but no sonographic evidence for an intrauterine pregnancy (IUP) or ectopic pregnancy (EP). This term is a classification and not a final diagnosis.
This study aimed to evaluate the diagnostic value of the Inexscreen test on the outcome of patients with pregnancies of unknown location.
In this prospective study, a total of 251 patients with a diagnosis of pregnancy of unknown location at the gynecologic emergency department of the La Conception Hospital, Marseille, France, between June 2015 and February 2019 were included. The Inexscreen (semiquantitative determination of intact human urinary chorionic gonadotropin) test was performed on patients with a diagnosis of pregnancy of unknown location. They participated in the study after information and consent collection. The main outcome measures (sensitivity, specificity, predictive values, and the Youden index) of Inexscreen were calculated for the diagnosis of abnormal pregnancy (nonprogressive pregnancy) and ectopic pregnancy.
The sensitivity and specificity of Inexscreen for the diagnosis of abnormal pregnancy in patients with pregnancy of unknown location were 56.3% (95% confidence interval, 47.0%-65.1%) and 62.8% (95% confidence interval, 53.1%-71.5%), respectively. The sensitivity and specificity of Inexscreen for the diagnosis of ectopic pregnancy in patients with pregnancy of unknown location were 81.3% (95% confidence interval, 57.0%-93.4%) and 55.6% (95% confidence interval, 48.6%-62.3%), respectively. The positive predictive value and negative predictive value of Inexscreen for ectopic pregnancy were 12.9% (95% confidence interval, 7.7%-20.8%) and 97.4% (95% confidence interval, 92.5%-99.1%), respectively.
Inexscreen is a rapid, non-operator-dependent, noninvasive, and inexpensive test that allows the selection of patients at high risk of ectopic pregnancy in case of pregnancy of unknown location. This test allows an adapted follow-up according to the technical platform available in a gynecologic emergency service.
不明部位妊娠(PUL)是指妊娠试验呈阳性,但超声检查未发现宫内妊娠(IUP)或异位妊娠(EP)证据时所使用的术语。该术语是一种分类,而非最终诊断。
本研究旨在评估Inexscreen检测对不明部位妊娠患者结局的诊断价值。
在这项前瞻性研究中,纳入了2015年6月至2019年2月期间在法国马赛拉孔ception医院妇科急诊科诊断为不明部位妊娠的251例患者。对诊断为不明部位妊娠的患者进行Inexscreen(完整人尿绒毛膜促性腺激素的半定量测定)检测。在收集信息并获得同意后,他们参与了研究。计算Inexscreen用于诊断异常妊娠(非进行性妊娠)和异位妊娠的主要结局指标(敏感性、特异性、预测值和尤登指数)。
Inexscreen对不明部位妊娠患者诊断异常妊娠的敏感性和特异性分别为56.3%(95%置信区间,47.0%-65.1%)和62.8%(95%置信区间,53.1%-71.5%)。Inexscreen对不明部位妊娠患者诊断异位妊娠的敏感性和特异性分别为81.3%(95%置信区间,57.0%-93.4%)和55.6%(95%置信区间,48.6%-62.3%)。Inexscreen对异位妊娠的阳性预测值和阴性预测值分别为12.9%(95%置信区间,7.7%-20.8%)和97.4%(95%置信区间,92.5%-99.1%)。
Inexscreen是一种快速、非操作人员依赖、非侵入性且廉价的检测方法,可在不明部位妊娠时筛选出异位妊娠高危患者。该检测可根据妇科急诊服务中可用的技术平台进行适应性随访。